Cargando…

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()

BACKGROUND: Although numerous clinical trials have evaluated the body weight change achieved using diabetes medications alone or in combinations, the composition of body weight change in these clinical trials has rarely been assessed. OBJECTIVE: We aimed to evaluate the effects of gliclazide, metfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hua, Ni, Yafang, Yang, Shuo, Li, Huizhi, Li, Xu, Feng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898190/ https://www.ncbi.nlm.nih.gov/pubmed/24465050 http://dx.doi.org/10.1016/j.curtheres.2013.10.002

Ejemplares similares

Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria
por: Pan, Qingrong, et al.
Publicado: (2018)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
por: Song, Lulu, et al.
Publicado: (2021)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Wang, Na, et al.
Publicado: (2018)

Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
por: Zhang, Rong, et al.
Publicado: (2022)

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
por: Wang, Guang, et al.
Publicado: (2014)

Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
por: Pan, Qingrong, et al.
Publicado: (2016)

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017)

Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
por: Mo, Dan, et al.
Publicado: (2019)

Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin
por: Aghili, Rokhsareh, et al.
Publicado: (2014)

Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
por: Al-Gareeb, Ali I., et al.
Publicado: (2016)

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: Jin, Hongmei, et al.
Publicado: (2022)

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone
por: Ristic, S, et al.
Publicado: (2006)

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021)

Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study
por: Song, Lu-Lu, et al.
Publicado: (2020)

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
por: Banik, Sujan, et al.
Publicado: (2018)

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial
por: Feng, Wen‐Huan, et al.
Publicado: (2018)

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset
por: Fernandez, Elizabeth, et al.
Publicado: (2019)

Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
por: Zhang, Minchun, et al.
Publicado: (2019)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
por: Abbasi, Mehran Mesgari, et al.
Publicado: (2016)

Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal
por: Chen, Zhong, et al.
Publicado: (2016)

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
por: Zheng, Miao-yan, et al.
Publicado: (2013)

Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance
por: Yun, Peng, et al.
Publicado: (2016)

Simultaneous Determination of Metformin, Nateglinide and Gliclazide in Pharmaceutical Preparations Using Micellar Liquid Chromatography
por: El-Wasseef, Dalia Rashad
Publicado: (2012)

Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
por: Fang, Hui, et al.
Publicado: (2020)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022)

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
por: Uzui, Hiroyasu, et al.
Publicado: (2011)

Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China
por: An, Yu, et al.
Publicado: (2022)

The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus
por: Heo, Eunyoung, et al.
Publicado: (2021)

Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone
por: Tseng, Chin-Hsiao
Publicado: (2019)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
por: Alsharidah, Mansour, et al.
Publicado: (2018)

Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
por: Yang, Hae Kyung, et al.
Publicado: (2019)

Effect of Metformin, Acarbose and Their Combination on the Serum Visfatin Level in Nicotinamide/Streptozocin-Induced Type 2 Diabetic Rats
por: Salemi, Zahra, et al.
Publicado: (2016)

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
por: Polavarapu, Nareen Krishna, et al.
Publicado: (2020)

Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_psmffbfo4lgeklcsvmfj1p6805